Subscribe
24 Oct 2024 11:22 AM
In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.
25 Apr 2025 10:14 AM
25 Apr 2025 9:06 AM
25 Apr 2025 8:32 AM
24 Apr 2025 10:06 PM
11 Apr 2025 8:57 AM
10 Apr 2025 12:05 PM
10 Apr 2025 9:39 AM
09 Apr 2025 9:59 AM